Suppr超能文献

喹硫平显著提高放射疗法在 Hep3B 异种移植小鼠模型中对抗肝癌进展的疗效。

Quetiapine Significantly Improves the Effectiveness of Radiotherapy in Combating Hepatocellular Carcinoma Progression in a Hep3B Xenograft Mouse Model.

机构信息

Division of Urology, Department of Surgery, National Yang-Ming Chiao Tung University Hospital, Yilan, Taiwan, R.O.C.

Department of Radiation Oncology, Chang Bing Show Chwan Memorial Hospital, Changhua, Taiwan, R.O.C.

出版信息

In Vivo. 2024 May-Jun;38(3):1079-1093. doi: 10.21873/invivo.13542.

Abstract

BACKGROUND/AIM: In hepatocellular carcinoma (HCC) treatment, radiotherapy (RT) stands as a pivotal approach, yet the emergence of radioresistance poses a formidable challenge. This study aimed to explore the potential synergy between quetiapine and RT for HCC treatment.

MATERIALS AND METHODS

A Hep3B xenograft mouse model was used, the investigation tracked tumor progression, safety parameters, and molecular mechanisms.

RESULTS

The findings revealed a synergistic anti-HCC effect when quetiapine was coupled with RT that prolonged tumor growth time and a significantly higher growth inhibition rate compared to the control group. Safety assessments indicated minimal pathological changes, suggesting potential of quetiapine in mitigating RT-induced alterations in liver and kidney functions. Mechanistically, the combination suppressed metastasis and angiogenesis-related proteins, while triggering the activation of apoptosis-related proteins via targeting Epidermal growth factor receptor (EGFR)-mediated signaling.

CONCLUSION

The potential of the quetiapine and RT combination is emphasized, offering enhanced anti-HCC efficacy, a safety profile, and positioning quetiapine as a radiosensitizer for HCC treatment.

摘要

背景/目的:在肝细胞癌(HCC)治疗中,放射治疗(RT)是一种重要的方法,但出现放射抗性是一个巨大的挑战。本研究旨在探讨喹硫平与 RT 联合治疗 HCC 的潜在协同作用。

材料和方法

使用 Hep3B 异种移植小鼠模型,研究跟踪肿瘤进展、安全性参数和分子机制。

结果

研究结果显示,喹硫平与 RT 联合使用具有协同抗 HCC 作用,可延长肿瘤生长时间,与对照组相比,生长抑制率显著提高。安全性评估表明,病理变化最小,提示喹硫平有可能减轻 RT 引起的肝肾功能改变。机制上,该联合抑制转移和血管生成相关蛋白,同时通过靶向表皮生长因子受体(EGFR)介导的信号转导,触发凋亡相关蛋白的激活。

结论

强调了喹硫平与 RT 联合应用的潜力,具有增强的抗 HCC 疗效、安全性,并将喹硫平定位为 HCC 治疗的放射增敏剂。

相似文献

3
The inhibitory effect and mechanism of quetiapine on tumor progression in hepatocellular carcinoma in vivo.
Environ Toxicol. 2022 Jan;37(1):92-100. doi: 10.1002/tox.23380. Epub 2021 Oct 9.
7
Synergistic efficacy of curcumin and anti-programmed cell death-1 in hepatocellular carcinoma.
Life Sci. 2021 Aug 15;279:119359. doi: 10.1016/j.lfs.2021.119359. Epub 2021 Mar 19.
8
Foretinib demonstrates anti-tumor activity and improves overall survival in preclinical models of hepatocellular carcinoma.
Angiogenesis. 2012 Mar;15(1):59-70. doi: 10.1007/s10456-011-9243-z. Epub 2011 Dec 21.
9
Preclinical evaluation of combined TKI-258 and RAD001 in hepatocellular carcinoma.
Cancer Chemother Pharmacol. 2013 Jun;71(6):1417-25. doi: 10.1007/s00280-013-2139-4. Epub 2013 Apr 2.
10
Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma progression by suppressing STAT3 phosphorylation.
J Exp Clin Cancer Res. 2019 May 9;38(1):189. doi: 10.1186/s13046-019-1193-0.

引用本文的文献

本文引用的文献

2
Brexpiprazole suppresses cell proliferation and de novo lipogenesis through AMPK/SREBP1 pathway in colorectal cancer.
Environ Toxicol. 2023 Oct;38(10):2352-2360. doi: 10.1002/tox.23871. Epub 2023 Jun 22.
6
Antipsychotic exposure is an independent risk factor for breast cancer: A systematic review of epidemiological evidence.
Front Oncol. 2022 Dec 15;12:993367. doi: 10.3389/fonc.2022.993367. eCollection 2022.
7
COX-2 Acts as a Key Mediator of Trifluoperazine-induced Cell Death in U87MG Glioma Cells.
Anticancer Res. 2022 Dec;42(12):5773-5781. doi: 10.21873/anticanres.16084.
9
Treatment of cancer with antipsychotic medications: Pushing the boundaries of schizophrenia and cancer.
Neurosci Biobehav Rev. 2022 Oct;141:104809. doi: 10.1016/j.neubiorev.2022.104809. Epub 2022 Aug 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验